Skip to main content
Europlasma logo

Europlasma — Investor Relations & Filings

Ticker · ALEUP ISIN · FR001400CF13 LEI · 969500WYVNHBV1ABQ250 Euronext Growth Water supply; sewerage, waste management and remediation activities
Open in API
Filings indexed 506 across all filing types
Latest filing 2017-11-07 Notice of Dividend Amou…
Country FR France
Listing Euronext Growth ALEUP

About Europlasma

https://www.europlasma.com/en/

Europlasma is a company specializing in clean technology and energy solutions. Its core activities focus on the research, engineering, and application of plasma solutions for industrial purposes, particularly for the treatment of hazardous waste and gas. The company provides services for the destruction and valorization of asbestos waste. In the decarbonization sector, Europlasma transforms waste into Solid Recovered Fuel (SRF). Additionally, the company operates an industrial division that manufactures hollow bodies and anodized sheets for capacitors.

Recent filings

Filing Released Lang Actions
EUROPLASMA: Information relative au nombre total de droits de vote et d'actions composant le capital au 31/10/2017
Notice of Dividend Amount Classification · 95% confidence The document is a regulatory disclosure regarding the total number of voting rights and shares composing the capital of Europlasma as of October 31, 2017. This is a standard periodic regulatory requirement under French law (Article L. 233-8 II of the Commercial Code and 223-16 of the AMF General Regulation). Since it does not fit into specific categories like 'Major Shareholding Notification' (which tracks individual holders) or 'Share Issue' (which details specific capital changes), it falls under the general regulatory filing category.
2017-11-07 French
EUROPLASMA: Assemblée Générale des actionnaires du 26/10/2017
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a press release announcing the results of an Extraordinary General Meeting (Assemblée Générale Extraordinaire) held on October 26, 2017. It confirms that all resolutions proposed by the Board of Directors were approved by the shareholders. Since the document specifically reports the outcome of the voting process at a general meeting, it falls under the category of Declaration of Voting Results.
2017-10-26 French
EUROPLASMA: Assemblée Générale, nouvelle convocation
AGM Information Classification · 98% confidence The document is an announcement regarding a second convocation for an Extraordinary General Meeting (EGM) due to a failure to reach the quorum at the first meeting. It provides details on the meeting date, location, and instructions for shareholders on how to participate or vote. While it relates to an AGM/EGM, it is an announcement of the meeting process rather than the presentation materials (AGM-R) or the final voting results (DVA). It fits best as a regulatory filing regarding meeting logistics.
2017-10-10 French
EUROPLASMA: Information relative aux droits de vote et actions composant le capital au 30/09/2017
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a regulatory disclosure from Europlasma regarding the total number of voting rights and shares composing its capital as of September 30, 2017. This is a standard periodic regulatory requirement under French law (Article L. 233-8 II of the Commercial Code and 223-16 of the AMF General Regulation). Since it does not fit into specific categories like 'Major Shareholding Notification' (which tracks changes in ownership by third parties) or 'Share Issue' (which focuses on the act of issuance), it falls under the general regulatory filing category.
2017-10-10 French
Europlasma: ERRATUM
AGM Information Classification · 95% confidence The document is a short announcement (erratum) regarding a correction to a resolution for an upcoming shareholder meeting. It directs shareholders to the official text published in the BALO and on the company website. Since it is a regulatory announcement regarding meeting materials rather than the meeting materials themselves or a full report, it falls under the category of general regulatory filings.
2017-09-26 French
Europlasma: Bilan de la stratégie 2014-2017 et perpectives de la croissance
Regulatory Filings Classification · 95% confidence The document is a detailed strategic review and business update from Europlasma, covering operational progress in various sectors (plasma solutions, renewable energy, asbestos treatment) and outlining future financing plans, including an upcoming Extraordinary General Meeting (AGE) to discuss the issuance of new warrants (BSAR C). While it mentions an upcoming meeting, it is not a proxy statement itself, nor is it a formal financial report. It functions as a comprehensive management update on strategy and outlook, which aligns best with the 'Management Reports' (MDA) category, as it provides management's detailed explanation of business trends, operational status, and future outlook.
2017-09-26 French

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.